• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Circumstances surrounding end-of-life in pediatric patients pre- and post-heart transplant: a report from the Pediatric Heart Transplant Society.儿童心脏移植患者在移植前后临终状况的相关因素:来自儿科心脏移植协会的报告。
Pediatr Transplant. 2022 Mar;26(2):e14196. doi: 10.1111/petr.14196. Epub 2021 Nov 24.
2
Three decades of collaboration through the Pediatric Heart Transplant Society Registry: A journey through registry data with a highlight on children with single ventricle anatomy.通过儿科心脏移植协会登记处开展的三十年合作:从登记处数据看一路走来的历程,重点关注单心室解剖结构患儿。
Pediatr Transplant. 2024 Feb;28(1):e14615. doi: 10.1111/petr.14615. Epub 2023 Oct 9.
3
The End-of-Life Experience of Pediatric Heart Transplant Recipients.小儿心脏移植受者的临终体验
J Pain Symptom Manage. 2017 May;53(5):927-931. doi: 10.1016/j.jpainsymman.2016.12.334. Epub 2017 Jan 4.
4
A comprehensive strategy in donor acceptance: Impact on pediatric waitlist and heart transplant outcomes.供体接受的综合策略:对儿科等待名单和心脏移植结果的影响。
Pediatr Transplant. 2020 Sep;24(6):e13764. doi: 10.1111/petr.13764. Epub 2020 Jun 14.
5
Inferior Outcomes on the Waiting List in Low-Volume Pediatric Heart Transplant Centers.低容量儿科心脏移植中心的候补名单上的不良结果。
Am J Transplant. 2017 Jun;17(6):1515-1524. doi: 10.1111/ajt.14252. Epub 2017 Mar 30.
6
Improved heart transplant survival for children with congenital heart disease and heterotaxy syndrome in the current era: An analysis from the pediatric heart transplant society.先天性心脏病和心脏异位综合征患儿心脏移植存活率的提高:来自儿科心脏移植协会的分析。
J Heart Lung Transplant. 2021 Oct;40(10):1153-1163. doi: 10.1016/j.healun.2021.07.008. Epub 2021 Jul 23.
7
Waitlist and Post-Heart Transplant Outcomes for Children with Kawasaki Disease in the United States.美国川崎病患儿的候补名单和心脏移植后结局。
J Pediatr. 2021 Aug;235:281-283.e4. doi: 10.1016/j.jpeds.2021.05.007. Epub 2021 May 10.
8
Risk factors for mortality or delisting of patients from the pediatric heart transplant waiting list.导致儿科心脏移植候补患者死亡或被取消候补资格的风险因素。
J Thorac Cardiovasc Surg. 2014 Jan;147(1):462-8. doi: 10.1016/j.jtcvs.2013.09.018. Epub 2013 Nov 1.
9
Mortality, Resource Utilization, and Inpatient Costs Vary Among Pediatric Heart Transplant Indications: A Merged Data Set Analysis From the United Network for Organ Sharing and Pediatric Health Information Systems Databases.儿科心脏移植适应证的死亡率、资源利用和住院费用存在差异:来自美国器官共享联合网络和儿科健康信息系统数据库的合并数据集分析。
J Card Fail. 2019 Jan;25(1):27-35. doi: 10.1016/j.cardfail.2018.11.014. Epub 2018 Nov 25.
10
Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy.扩张型心肌病患儿心脏移植登记时左心室扩张与登记后及移植后早期死亡率的关联
Circ Heart Fail. 2009 Nov;2(6):591-8. doi: 10.1161/CIRCHEARTFAILURE.108.839001. Epub 2009 Sep 28.

引用本文的文献

1
Palliative care for the cardiothoracic transplant recipient.心胸移植受者的姑息治疗。
JHLT Open. 2025 Jun 24;9:100329. doi: 10.1016/j.jhlto.2025.100329. eCollection 2025 Aug.
2
End-stage care for children after heart transplant.儿童心脏移植后的终末期护理。
Front Transplant. 2023 Jun 27;2:1221166. doi: 10.3389/frtra.2023.1221166. eCollection 2023.
3
Palliative Care Across the Life Span for Children With Heart Disease: A Scientific Statement From the American Heart Association.儿童心脏病全生命周期舒缓医疗:美国心脏协会科学声明
Circ Cardiovasc Qual Outcomes. 2023 Feb;16(2):e000114. doi: 10.1161/HCQ.0000000000000114. Epub 2023 Jan 12.
4
State of the science and future research directions in palliative and end-of-life care in paediatric cardiology: a report from the Harvard Radcliffe Accelerator Workshop.儿科心脏病学姑息治疗和临终关怀的科学现状和未来研究方向:哈佛拉德克利夫加速器研讨会的报告。
Cardiol Young. 2022 Mar;32(3):431-436. doi: 10.1017/S104795112100233X. Epub 2021 Jun 24.

本文引用的文献

1
State of the science and future research directions in palliative and end-of-life care in paediatric cardiology: a report from the Harvard Radcliffe Accelerator Workshop.儿科心脏病学姑息治疗和临终关怀的科学现状和未来研究方向:哈佛拉德克利夫加速器研讨会的报告。
Cardiol Young. 2022 Mar;32(3):431-436. doi: 10.1017/S104795112100233X. Epub 2021 Jun 24.
2
Barriers to Optimal End-of-Life Care for Adolescents and Young Adults With Cancer: Bereaved Caregiver Perspectives.癌症青少年和年轻患者临终关怀的障碍:丧亲照料者的观点。
J Natl Compr Canc Netw. 2021 Feb 11;19(5):528-533. doi: 10.6004/jnccn.2020.7645. Print 2021 May.
3
Palliative Care?! But This Child's Not Dying: The Burgeoning Partnership Between Pediatric Cardiology and Palliative Care.姑息治疗?!但这个孩子没有生命危险:儿科心脏病学和姑息治疗之间新兴的合作关系。
Can J Cardiol. 2020 Jul;36(7):1041-1049. doi: 10.1016/j.cjca.2020.04.041. Epub 2020 May 11.
4
Experiences at the End of Life From the Perspective of Bereaved Parents: Results of a Qualitative Focus Group Study.临终体验的研究:丧亲父母的观点——一项定性焦点小组研究的结果
Am J Hosp Palliat Care. 2020 Jun;37(6):424-432. doi: 10.1177/1049909119895496. Epub 2019 Dec 30.
5
Medical and end-of-life decision making in adolescents' pre-heart transplant: A descriptive pilot study.青少年心脏移植前的医疗和临终决策:一项描述性试点研究。
Palliat Med. 2020 Mar;34(3):272-280. doi: 10.1177/0269216319874689. Epub 2019 Oct 24.
6
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report - 2019; Focus theme: Donor and recipient size match.国际心脏和肺移植协会国际胸科器官移植登记处:2019年第二十二份小儿心脏移植报告;重点主题:供体与受体大小匹配
J Heart Lung Transplant. 2019 Oct;38(10):1028-1041. doi: 10.1016/j.healun.2019.08.002. Epub 2019 Aug 10.
7
Palliative care in pediatric heart failure and transplantation.儿科心力衰竭和移植中的姑息治疗。
Curr Opin Pediatr. 2019 Oct;31(5):611-616. doi: 10.1097/MOP.0000000000000799.
8
The Benefits and Burdens of Pediatric Palliative Care and End-of-Life Research: A Systematic Review.儿科姑息治疗和临终关怀研究的利弊:系统评价。
J Palliat Med. 2019 Aug;22(8):915-926. doi: 10.1089/jpm.2018.0483. Epub 2019 Mar 5.
9
Communication about prognosis and end-of-life in pediatric organ failure and transplantation.关于小儿器官衰竭与移植中预后及临终关怀的沟通。
Pediatr Transplant. 2019 May;23(3):e13373. doi: 10.1111/petr.13373. Epub 2019 Feb 7.
10
Prediction of mortality following pediatric heart transplant using machine learning algorithms.使用机器学习算法预测小儿心脏移植后的死亡率。
Pediatr Transplant. 2019 May;23(3):e13360. doi: 10.1111/petr.13360. Epub 2019 Jan 29.

儿童心脏移植患者在移植前后临终状况的相关因素:来自儿科心脏移植协会的报告。

Circumstances surrounding end-of-life in pediatric patients pre- and post-heart transplant: a report from the Pediatric Heart Transplant Society.

机构信息

Department of Pediatrics, Michigan Medicine, Ann Arbor, Michigan, USA.

University of Michigan Congenital Heart Center, Ann Arbor, Michigan, USA.

出版信息

Pediatr Transplant. 2022 Mar;26(2):e14196. doi: 10.1111/petr.14196. Epub 2021 Nov 24.

DOI:10.1111/petr.14196
PMID:34820983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10466174/
Abstract

BACKGROUND

Although mortality has decreased considerably in pediatric heart transplantation, waitlist and post-transplant death rates remain notable. End-of-life focused research in this population, however, is very limited. This Pediatric Heart Transplant Society study aimed to describe the circumstances surrounding death of pediatric heart transplant patients.

METHODS

A retrospective analysis of the multi-institutional, international, Pediatric Heart Transplant Society registry was conducted. Descriptive statistics and univariate analyses were performed to 1) describe end-of-life in pediatric pre- and post-heart transplant patients and 2) examine associations between location of death and technological interventions at end-of-life with demographic and disease factors.

RESULTS

Of 9217 patients (0-18 years) enrolled in the registry between 1993 and 2018, 2804 (30%) deaths occurred; 1310 while awaiting heart transplant and 1494 post-heart transplant. The majority of waitlist deaths (89%) occurred in the hospital, primarily in ICU (74%) with most receiving mechanical ventilation (77%). Fewer post-transplant deaths occurred in the hospital (22%). Out-of-hospital death was associated with older patient age (p < .01).

CONCLUSIONS

ICU deaths with high use of technological interventions at end-of-life were common, particularly in patients awaiting heart transplant. In this high mortality population, findings raise challenging considerations for clinicians, families, and policy makers on how to balance quality of life amidst high risk for hospital-based death.

摘要

背景

尽管儿科心脏移植患者的死亡率已大幅下降,但候补名单和移植后死亡率仍然显著。然而,该人群的临终关怀研究非常有限。这项儿科心脏移植协会的研究旨在描述儿科心脏移植患者死亡的情况。

方法

对多机构、国际儿科心脏移植协会注册中心进行了回顾性分析。采用描述性统计和单变量分析,1)描述儿科心脏移植患者在移植前和移植后的临终情况,2)检查临终时死亡地点和技术干预与人口统计学和疾病因素之间的关系。

结果

在 1993 年至 2018 年间注册的 9217 名患者(0-18 岁)中,有 2804 名(30%)死亡;1310 人在等待心脏移植,1494 人在心脏移植后。候补名单上死亡的大多数(89%)发生在医院,主要是在 ICU(74%),其中大多数人接受机械通气(77%)。在医院的移植后死亡较少(22%)。院外死亡与患者年龄较大有关(p<0.01)。

结论

在等待心脏移植的患者中,临终时 ICU 死亡与高频率使用技术干预措施很常见。在这个高死亡率的人群中,这些发现给临床医生、家属和政策制定者带来了严峻的挑战,需要考虑如何在高医院死亡风险的情况下平衡生活质量。